Network pharmacology and artificial intelligence in traditional Chinese medicine for Alzheimer’s disease: A comprehensive review
DOI:
https://doi.org/10.56511/JIPBS.2025.12103Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by the accumulation of amyloid-beta, tau hyperphosphorylation, neuroinflammation, and oxidative stress. With current pharmacological treatments providing symptomatic relief, the need for other therapeutic approaches becomes evident. Traditional Chinese Medicine, with its multi-component and multi-target approach, offers promising potential for the management of AD, but the complex formulations have proved challenging to discern precise mechanisms of therapy. Network pharmacology, a systems biology approach, has emerged as a powerful tool in understanding the mechanisms of action of TCM by mapping bioactive compounds to AD-related pathways. This method enables the identification of synergistic interactions and key molecular targets, facilitating drug discovery and optimization. Furthermore, AI, particularly machine learning and deep learning algorithms, has revolutionized TCM research by analyzing large datasets, predicting compound-target interactions, and enabling personalized treatment approaches. AI-driven virtual screening and computational modeling have rapidly accelerated the identification of potential neuroprotective compounds, such as curcumin, ginsenosides, and huperzine A, which modulate multiple AD-associated pathways. The integration of network pharmacology and AI offers a systematic framework for validating TCM formulations and optimizing their therapeutic potential. This review highlights recent advancements in AI-assisted TCM research, discusses key bioactive compounds, and explores their mechanisms in AD treatment. While standardization and regulatory approval continue to be challenging, the synthesis of ancient knowledge with contemporary computing technologies holds enormous promise for effective, multi-target interventions for AD, thereby ushering in a new wave of innovative therapeutic approaches.
Keywords:
Alzheimer’s disease, Traditional Chinese Medicine, Network pharmacology, Artificial intelligence, Multi-target therapyDownloads
References
Gaugler J, James B, Johnson T. Alzheimer’s association report: 2024 Alzheimer’s disease facts and figures. Alzheimers Dement. 2024; 20(5):3708 - 821.
Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid β - based therapy for Alzheimer’s disease: challenges, successes and future. Sig Transduct Target Ther. 2023; 8:248.
Zhai Y, Liu L, Zhang F, Chen X, Wang H, Zhou J, et al. Network pharmacology: a crucial approach in traditional Chinese medicine research. Chin Med. 2025; 20:8.
Li L, Yang L, Yang L, He C, He Y, Chen L, et al. Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine. Chin Med. 2023; 18:146.
Song Z, Chen G, Chen CY. AI empowering traditional Chinese medicine? Chem Sci. 2024;15(41):16844 - 86.
Huanbutta K, Burapapadh K, Kraisit P, Sriamornsak P, Ganokratanaa T, Suwanpitak K, et al. Artificial intelligence - driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post - market surveillance. Eur J Pharm Sci. 2024;203:106938.
Rajesh Y, Kanneganti TD. Innate immune cell death in neuroinflammation and Alzheimer's disease. Cells. 2022;11(12):1885.
Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage, and neurodegenerative diseases. Neural Regen Res. 2013;8(21):2003 - 14.
Jiang Q, Yang S, He S, Li F. AI drug discovery tools and analysis technology: New methods aid in studying the compatibility of Traditional Chinese Medicine. Pharmacol Res Mod Chin Med. 2025; 14:100566.
Zhou Z, Chen B, Chen S, Lin M, Chen Y, Jin S. Applications of network pharmacology in traditional Chinese medicine research. Evid Based Complement Alternat Med. 2020; 2020:1646905.
Liang YT. Emerging concepts and functions of autophagy as a regulator of synaptic components and plasticity. Cells. 2019;8(1):34.
Shan Y, Zhao J, Wei K, Jiang P, Xu L, Chang C, et al. A comprehensive review of Tripterygium wilfordii Hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions. Front Pharmacol. 2023; 14:1282610.
Wang K, Li K, Chen Y, Wei G, Yu H, Li Y, et al. Computational network pharmacology - based strategy to capture key functional components and decode the mechanism of Chai - Hu - Shu - Gan - San in treating depression. Front Pharmacol. 2021; 12:782060.
Zeng J, Jia X. Systems theory - driven framework for AI integration into the holistic material basis research of traditional Chinese medicine. Engineering. 2024; 40:28 - 50.
Chen Q, Chen G, Wang Q. Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine. Planta Med. 2025; 91(4):361 - 377. doi: 10.1055/a - 2512 - 8928.
Zhai Y, Liu L, Zhang F, Chen X, Wang H, Zhou J, et al. Network pharmacology: a crucial approach in traditional Chinese medicine research. Chin Med. 2025; 20(1):1 - 20.
T ấ t PV, Ha VL, Son NLH, Quang NM. Using network pharmacology analysis and molecular docking of quercetin compound for treatment of Alzheimer. Tap Chi Xuc Tac Va Hap Phu. 2025; 13(4):50 - 6.
Zhang P, Zhang D, Zhou W, Wang L, Wang B, Zhang T, et al. Network pharmacology: towards the artificial intelligence - based precision traditional Chinese medicine. Brief Bioinform. 2024; 25(1):bbad518
Wu X, Cao S, Zou Y, Wu F. Traditional Chinese Medicine studies for Alzheimer’s disease via network pharmacology based on entropy and random walk. PLoS One. 2023; 18(11):e0294772.
Kamatham PT, Shukla R, Khatri DK, Vora LK. Pathogenesis, diagnostics, and therapeutics for Alzheimer’s disease: Breaking the memory barrier. Ageing Res Rev. 2024; 101:102481.
Zhou E, Shen Q, Hou Y. Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review. Front Pharmacol. 2024; 15:1181183.
Yuan L, Yang L, Zhang S, Xu Z, Qin J, Shi Y, et al. Development of a tongue image - based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study. EClinicalMedicine. 2023; 57:101834.
Rane NL, Mallick SK, Kaya O, Rane J. Emerging trends and future directions in machine learning and deep learning architectures. In: Applied Machine Learning and Deep Learning: Architectures and Techniques. Deep Science Publishing; 2024. p. 192 - 211.
Theodorakis N, Feretzakis G, Tzelves L, Paxinou E, Hitas C, Vamvakou G, et al. Integrating machine learning with multi - omics technologies in geroscience: towards personalized medicine. J Pers Med. 2024; 14(9):931.
Choudhury C, Arul Murugan N, Priyakumar UD. Structure - based drug repurposing: Traditional and advanced AI/ML - aided methods. Drug Discov Today. 2022; 27(7):1847 – 61.
Wang X, Wang Y, Yuan T, Wang H, Zeng Z, Tian L, et al. Network pharmacology provides new insights into the mechanism of traditional Chinese medicine and natural products used to treat pulmonary hypertension. Phytomedicine. 2024; 135:156062.
Chen J, Luo P, Wang C, Yang C, Bai Y, He X, et al. Integrated single - cell transcriptomics and proteomics reveal cellular - specific responses and microenvironment remodeling in aristolochic acid nephropathy. JCI Insight. 2022; 7(16):e157360.
Zhang Z, Li B, Huang J, Huang S, He D, Peng W, et al. Network pharmacology analysis of the active components of the traditional Chinese medicine Zuojinwan in patients with gastric cancer. Med Sci Monit. 2020; 26:e923327 - 1 – e923327 - 16.
Liu DX, Zhang M, Sun XH, Qu Y, Zhang F. WITHDRAWN: Self - assembly of Natural Products of TCM and Bioactive Materials. Pharmacol Res - Mod Chin Med. 2024.
Mohr AE, Ortega - Santos CP, Whisner CM, Klein - Seetharaman J, Jasbi P. Navigating challenges and opportunities in multi - omics integration for personalized healthcare. Biomedicines. 2024; 12(7):1496.
Kale M, Wankhede N, Pawar R, Ballal S, Kumawat R, Goswami M, et al. AI - driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling. Ageing Res Rev. 2024; 101:10249.
Weissler EH, Naumann T, Andersson T, Ranganath R, Elemento O, Luo Y, et al. The role of machine learning in clinical research: transforming the future of evidence generation. Trials. 2021; 22:537.
Vazquez - Zapien GJ, Mata - Miranda MM, Garibay - Gonzalez F, Sanchez - Brito M. Artificial intelligence model validation before its application in clinical diagnosis assistance. World J Gastroenterol. 2022; 28(5):602 - 4.
Wang H, Chen Y, Wang L, Liu Q, Yang S, Wang C. Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol. 2023; 14:1265178.
Wainwright CL, Teixeira MM, Adelson DL, Braga FC, Buenz EJ, Campana PRV, et al. Future directions for the discovery of natural product - derived immunomodulating drugs: an IUPHAR positional review. Pharmacol Res. 2022; 177:106076.
Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC. Using digital technologies in clinical trials: current and future applications. Contemp Clin Trials. 2020; 100:106219.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Sinchana Bhat, RAMDAS BHAT, Preeti Shanbhag, Ranjan K, Subrahmanya Pradeep, Yuktha S K

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at